The endocannabinoid system as an emerging target of pharmacotherapy

P Pacher, S Bátkai, G Kunos - Pharmacological reviews, 2006 - ASPET
The recent identification of cannabinoid receptors and their endogenous lipid ligands has
triggered an exponential growth of studies exploring the endocannabinoid system and its …

[HTML][HTML] Curcumin in depression: potential mechanisms of action and current evidence—a narrative review

T Ramaholimihaso, F Bouazzaoui… - Frontiers in psychiatry, 2020 - frontiersin.org
Major depressive disorder (MDD) is one of the most prevalent and debilitating disorders.
Current available treatments are somehow limited, so alternative therapeutic approaches …

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

DM Lambert, CJ Fowler - Journal of medicinal chemistry, 2005 - ACS Publications
As far as can be ascertained from archeological sources, preparations of the hemp
Cannabis sativa L. were widely used by humans for either therapeutic or ritual purposes in …

Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings

BA Johnson - Biochemical pharmacology, 2008 - Elsevier
The past decade has seen an expansion of research and knowledge on pharmacotherapy
for the treatment of alcohol dependence. The Food and Drug Administration (FDA)-approved …

Deficiency in Na, K-ATPase α isoform genes alters spatial learning, motor activity, and anxiety in mice

AE Moseley, MT Williams, TL Schaefer… - Journal of …, 2007 - Soc Neuroscience
Several disorders have been associated with mutations in Na, K-ATPase α isoforms (rapid-
onset dystonia parkinsonism, familial hemiplegic migraine type-2), as well as reduction in …

Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test

MN Hill, BB Gorzalka - European Neuropsychopharmacology, 2005 - Elsevier
These experiments aimed to assess whether enhanced activity at the cannabinoid CB1
receptor elicits antidepressant-like effects. To examine this we administered 1 and 5 mg/kg …

Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential

CH Ashton, PB Moore, P Gallagher… - Journal of …, 2005 - journals.sagepub.com
Bipolar affective disorder is often poorly controlled by prescribed drugs. Cannabis use is
common in patients with this disorder and anecdotal reports suggest that some patients take …

The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants

MN Hill, CJ Hillard, FR Bambico, S Patel… - Trends in …, 2009 - cell.com
The endocannabinoid system is a neuromodulatory system which is known to regulate
emotional, cognitive, neurovegetative and motivational processes. Substantial evidence has …

Cannabis: a treasure trove or pandora's box?

K Solymosi, A Köfalvi - Mini reviews in medicinal chemistry, 2017 - ingentaconnect.com
Background & Objective: Cannabis is one of the earliest cultivated plants. Cannabis of
industrial utility and culinary value is generally termed as hemp. Conversely, cannabis that is …

Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids

M Oz - Pharmacology & therapeutics, 2006 - Elsevier
Cannabinoids are a structurally diverse group of mostly lipophilic molecules that bind to
cannabinoid receptors. In fact, endogenous cannabinoids (endocannabinoids) are a class of …